Roche Holding AG (RHHBY)
37.77
-1.14
(-2.93%)
USD |
OTCM |
Nov 06, 16:00
Roche Enterprise Value: 273.64B for Nov. 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
November 06, 2024 | 273.64B |
November 05, 2024 | 280.91B |
November 04, 2024 | 284.22B |
November 01, 2024 | 283.14B |
October 31, 2024 | 280.27B |
October 30, 2024 | 284.41B |
October 29, 2024 | 286.90B |
October 28, 2024 | 289.83B |
October 25, 2024 | 291.49B |
October 24, 2024 | 290.98B |
October 23, 2024 | 289.13B |
October 22, 2024 | 282.69B |
October 21, 2024 | 284.03B |
October 18, 2024 | 285.05B |
October 17, 2024 | 282.06B |
October 16, 2024 | 281.99B |
October 15, 2024 | 283.78B |
October 14, 2024 | 282.57B |
October 11, 2024 | 282.63B |
October 10, 2024 | 280.65B |
October 09, 2024 | 277.72B |
October 08, 2024 | 276.83B |
October 07, 2024 | 275.04B |
October 04, 2024 | 273.64B |
October 03, 2024 | 276.89B |
Date | Value |
---|---|
October 02, 2024 | 281.93B |
October 01, 2024 | 283.01B |
September 30, 2024 | 287.54B |
September 27, 2024 | 288.75B |
September 26, 2024 | 288.88B |
September 25, 2024 | 286.90B |
September 24, 2024 | 287.54B |
September 23, 2024 | 284.67B |
September 20, 2024 | 284.35B |
September 19, 2024 | 284.41B |
September 18, 2024 | 285.37B |
September 17, 2024 | 283.59B |
September 16, 2024 | 282.82B |
September 13, 2024 | 282.18B |
September 12, 2024 | 279.63B |
September 11, 2024 | 270.84B |
September 10, 2024 | 286.07B |
September 09, 2024 | 282.18B |
September 06, 2024 | 290.98B |
September 05, 2024 | 291.94B |
September 04, 2024 | 293.91B |
September 03, 2024 | 295.25B |
August 30, 2024 | 302.71B |
August 29, 2024 | 300.86B |
August 28, 2024 | 298.69B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
213.58B
Minimum
May 02 2024
368.95B
Maximum
Dec 28 2021
289.68B
Average
288.99B
Median
Enterprise Value Benchmarks
Novo Nordisk AS | 466.15B |
Pfizer Inc | 211.99B |
Abbott Laboratories | 210.01B |
Eli Lilly and Co | 764.71B |
Novartis AG | 229.96B |
Enterprise Value Related Metrics
Earnings Yield | 4.89% |
Operating Earnings Yield | 6.75% |
Normalized Earnings Yield | 5.070 |